A new medication, baxdrostat, is reported to lower blood pressure and may offer long-lasting effects even after patients stop taking it. Across outlets, the drug is described as targeting a common underlying cause of high blood pressure, with improvements seen during an initial course of daily pills.
The reporting says patients take baxdrostat for about six to 12 months, during which blood-pressure levels improve. What stands out in multiple accounts is that the benefit can continue for as long as two years after stopping, with some patients reportedly needing no further hypertension medication. The articles frame the findings as potentially remarkable because they suggest a durable reversal rather than temporary control.
While the headlines differ slightly in emphasis—ranging from “cure”-style language to more cautious “common cause” framing—the core elements are consistent: baxdrostat, improvements during treatment, and sustained results up to two years post-therapy.
